Source comparison
Sermorelin GHRP-2 Acetate for Research: Quality Comparison
Before selecting a peptide supplier, compare synthesis method, purity verification, and storage handling. These factors determine whether your research yields reproducible data or inconsistent results requiring protocol redesign. Solid-phase peptide synthesis
This comparison does not assign a generated winner or score.
- Before selecting a peptide supplier, compare synthesis method, purity verification, and storage handling. These factors determine whether your research yields reproducible data or inconsistent results requiring protocol redesign.
- Solid-phase peptide synthesis (SPPS) with HPLC purification. Industry standard for research-grade peptides
- Third-party mass spectrometry confirming >98% purity, with COA (certificate of analysis) included per batch
- Cold-chain shipping with temperature data loggers; lyophilised storage at −20°C before reconstitution
- Full amino acid sequencing via Edman degradation or tandem MS to verify exact 29-AA sermorelin + 6-AA GHRP-2 structure
- Meets research reproducibility standards. Each batch traceable and verified
- Liquid-phase synthesis or recombinant expression. Lower cost but higher impurity risk
- In-house HPLC only, no independent COA
- Standard shipping without temperature monitoring; refrigerated storage claims without verification
- Sequence confirmation by supplier statement only, no third-party validation
- Adequate for preliminary work but insufficient for publication-quality studies
- Undisclosed synthesis method or "proprietary process"
- No purity documentation provided
- No cold-chain protocol; peptides shipped at ambient temperature
- No sequence verification available
- Unacceptable for any research requiring reproducibility or regulatory compliance
- Our experience working with research institutions shows the same pattern: peptide batches without third-party COAs produce GH release variance exceeding 40% between replicates, making dose-response curves unreliable. Verified >98% purity narrows that variance to under 8%, which is the threshold for publishable endocrine research.